Advertisement

Organisation › Details
Inositec AG
Inositec is pioneering the development of life-saving small molecule drugs based on inositol phosphate, a natural facilitator of diverse cellular functions. Using its broadly applicable Inositune™ technology to adjust the chemical and physical properties of inositol phosphate analogs, Inositec is developing a novel class of drugs initially focusing on two areas of high-unmet medical need: calcification disorders and Clostridium difficile infection. Inositec was founded in December 2015 based on the award-winning research of Dr Mattias Ivarsson, Prof Jean-Christophe Leroux and Prof Bastien Castagner at ETH Zurich, Switzerland. *
![]() |
Start | 2015-12-01 established (s-off) |
Group | Vifor Pharma (Group) | |
Predecessor | ETH Zürich (ETHZ) | |
![]() |
Industry | Inositune™ platform |
Industry 2 | small-molecule drug | |
![]() |
Person | Ivarrson, Mattias (Inositec 201610 CEO) |
Person 2 | Wacker, Michael (BioMedPartners 202007 before Polyneuron 201805– CBO before GlycoVaxyn CSO + Co-Founder) | |
![]() |
Region | Zürich ZH |
Country | Switzerland | |
Street | 1 Technoparkstr. | |
City | 8005 Zürich ZH | |
Tel | +41-44-271-0755 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2024-12-29 |
Advertisement

More documents for Vifor Pharma (Group)
- [1] Asceneuron S.A.. (10/6/23). "Press Release: Asceneuron Welcomes Barbara Angehrn Pavik as New CEO as It Gears Up for Next Phase of Growth". Lausanne....
- [2] T-Knife Therapeutics, Inc.. (1/5/22). "Press Release: T-knife Therapeutics Appoints Ronald Krasnow, J.D., as General Counsel". South San Francisco, CA & Paris....
- [3] Vifor Pharma AG. (12/14/21). "Press Release: CSL Limited Announces Tender Offer to Acquire Vifor Pharma Ltd (ad hoc)". St. Gallen....
- [4] Vifor Pharma AG. (11/22/21). "Press Release: Vifor Pharma to Spearhead Development of Vascular Calcification Field, through Acquisition of Sanifit Therapeutics and Inositec AG". St. Gallen, Palma & Zurich....
- [5] Vifor Pharma AG. (11/09/20). "Press Release: Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications". St. Gallen & Uniondale, NY....
- [6] Vifor Pharma AG. (10/20/20). "Press Release: Vifor Pharma and Cara Therapeutics Sign US License Agreement for i.v. Korsuva to Treat Dialysis Patients with Pruritus". St. Gallen & Stamford, CT....
- [7] ChemoCentryx Inc.. (11/25/19). "Press Release: ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA-Associated Vasculitis". Mountain View, CA & St...
- [8] Evotec SE. (11/6/19). "Press Release: Evotec and Vifor Pharma Form Joint Venture for Early Development in Nephrology". Hamburg & St. Gallen....
- [9] Santhera Pharmaceuticals AG. (11/4/19). "Press Release: Santhera Appoints New Chief Executive Officer". Pratteln....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top